Ebstein's anomaly may be caused by mutations in the sarcomere protein gene MYH7

Netherlands Heart Journal

Volumn 21, Issue 3, 2013, Pages 113-117

  van Engelen, K ^a,b   Postma, A V ^a   van de Meerakker, J B A ^a   Roos Hesselink, J W ^c   Helderman Van den Enden, A T J M ^d   Vliegen, H W ^e   Rahman, T ^f   Baars, M J H ^a   Sels, J W ^g   Bauer, U ^h   Pickardt, T ^h   Sperling, S R ⁱ   Moorman, A F M ^a   Keavney, B ^f   Goodship, J ^f   Klaassen, S ^j,k   Mulder, B J M ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g CATHARINA HOSPITAL   (Netherlands)

^h National Registry for Congenital Heart Defects ^*  (Germany)

ⁱ MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^j MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Cardiomyopathy; Ebstein anomaly; Genetics; Heart defects, Congenital; Isolated noncompaction of the ventricular myocardium

Indexed keywords

ALPHA ACTIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN BETA; TROPOMYOSIN; TROPONIN T;

BETA MYOSIN HEAVY CHAIN GENE; BICUSPID AORTIC VALVE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONGENITAL HEART DISEASE; CYANOSIS; DISEASE ASSOCIATION; EBSTEIN ANOMALY; ENVIRONMENTAL FACTOR; GENE; GENE MUTATION; GENETIC COUNSELING; HEART ARRHYTHMIA; HEART DEATH; HEART FAILURE; HEART VENTRICLE SEPTUM DEFECT; HEREDITY; HUMAN; PULMONARY ARTERY STENOSIS; REVIEW; SARCOMERE; THROMBOEMBOLISM; VENTRICULAR NONCOMPACTION;

EID: 84874705105     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-011-0141-1     Document Type: Review

References (31)

1. Attenhofer Jost CH, Connolly HM, Dearani JA, et al. Ebstein's anomaly. Circulation. 2007;115:277-85.
2. Attenhofer Jost CH, Connolly HM, Warnes CA, et al. Noncompacted myocardium in Ebstein's anomaly: initial description in three patients. J Am Soc Echocardiogr. 2004;17:677-80.
3. Attenhofer Jost CH, Connolly HM, O'Leary PW, et al. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc. 2005;80:361-8.
4. Sinkovec M, Kozelj M, Podnar T. Familial biventricular myocardial noncompaction associated with Ebstein's malformation. Int J Cardiol. 2005;102:297-302.
5. Budde BS, Binner P, Waldmuller S, et al. Noncompaction of the ventricular myocardium is associated with a de novo mutation in the beta-myosin heavy chain gene. PLoS One. 2007;2:e1362.
6. Bagur RH, Lederlin M, Montaudon M, et al. Images in cardiovascular medicine. Ebstein anomaly associated with left ventricular noncompaction. Circulation. 2008;118:e662-4.
7. Postma AV, van Engelen K, van de Meerakker JBA, et al. Mutations in the Sarcomere Protein Gene MYH7 in Ebstein's Anomaly. Circ Cardiovasc Genet. 2011;4:43-50.
8. Frescura C, Angelini A, Daliento L, et al. Morphological aspects of Ebstein's anomaly in adults. Thorac Cardiovasc Surg. 2000;48:203-8.
9. Correa-Villasenor A, Ferencz C, Neill CA, et al. Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington Infant Study Group. Teratology. 1994;50:137-47.
10. Firth HV. Congenital heart disease. In: Firth HV, Hurst JA, Hall JG, editors. Oxford desk reference clinical genetics. Oxford: Oxford University Press; 2006. p. 84-7.
11. Benson DW, Silberbach GM, Kavanaugh-McHugh A, et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest. 1999;104:1567-73.
12. Yang H, Lee CL, Young DC, et al. A rare case of interstitial del(1) (p34.3p36.11) diagnosed prenatally. Fetal Pediatr Pathol. 2004;23:251-5.
13. Miller MS, Rao PN, Dudovitz RN, et al. Ebstein anomaly and duplication of the distal arm of chromosome 15: report of two patients. Am J Med Genet A. 2005;139A:141-5.
14. Siebert JR, Barr Jr M, Jackson JC, et al. Ebstein's anomaly and extracardiac defects. Am J Dis Child. 1989;143:570-2.
15. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-16.
16. Jenni R, Oechslin E, Schneider J, et al. Echocardiographic and pathoanatomical characteristics of isolated left ventricular noncompaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86:666-71.
17. Aras D, Tufekcioglu O, Ergun K, et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J Card Fail. 2006;12:726-33.
18. Hoedemaekers YM, Caliskan K, Michels M, et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet. 2010;3:232-9.
19. Klaassen S, Probst S, Oechslin E, et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation. 2008;117:2893-901.
20. Monserrat L, Hermida-Prieto M, Fernandez X, et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J. 2007;28:1953-61.
21. Dellefave LM, Pytel P, Mewborn S, et al. Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation. Circ Cardiovasc Genet. 2009;2:442-9.
22. Chen H, Zhang W, Li D, et al. Analysis of ventricular hyper- trabeculation and noncompaction using genetically engineered mouse models. Pediatr Cardiol. 2009;30:626-34.
23. de Lange FJ, Moorman AF, Anderson RH, et al. Lineage and morphogenetic analysis of the cardiac valves. Circ Res. 2004;95:645-54.
24. Meilhac SM, Esner M, Kerszberg M, et al. Oriented clonal cell growth in the developing mouse myocardium underlies cardiac morphogenesis. J Cell Biol. 2004;164:97-109.
25. Ching YH, Ghosh TK, Cross SJ, et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet. 2005;37:423-8.
26. Lekanne Deprez RH, Muurling-Vlietman JJ, Hruda J, et al. Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene. J Med Genet. 2006;43:829-32.
27. Matsson H, Eason J, Bookwalter CS, et al. Alpha-cardiac actin mutations produce atrial septal defects. Hum Mol Genet. 2008;17:256-65.
28. Zhu L, Vranckx R, Van Khau KP, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006;38:343-9.
29. Guo DC, Pannu H, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet. 2007;39:1488-93.
30. Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000;36:493-500.
31. Charron P, Arad M, Arbustini E, et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2010;31:2715-26.